Subsequent Events - Additional Information (Details) - Subsequent Event - USD ($) $ / shares in Units, $ in Millions	Jul. 13, 2022	Jul. 11, 2022
Subsequent Event [Line Items]
Business combination, sale of stock transaction date	Jul. 13, 2022
Business combination, percentage of securities sold	15.00%
Upfront cash payment	$ 282.0
Milestone payment	$ 50.0
Entasis Therapeutics Holdings Inc
Subsequent Event [Line Items]
Business acquisition, date of acquisition		Jul. 11, 2022
Business combination, price per share of equity securities acquired		$ 2.20
Business combination, consideration transferred		$ 42.4
La Jolla Pharmaceutical
Subsequent Event [Line Items]
Merger Agreement Effective Date		Jul. 11, 2022
Business combination, price per share of equity securities acquired		$ 6.23